Chronic kidney disease (CKD) is associated with high risk for cardiovascular disease (CVD).
Gut microbiota-dependent metabolites trimethylamine (TMA), trimethylamine N-oxide …

Cardiometabolic diseases (CMDs) have been associated with changes in the composition of
the gut microbiota, with links between the host environment and microbiota identified in …

Trimethylamine-N-oxide (TMAO) is a product of dietary, gut microbiome, and tissues
metabolism. Elevated blood TMAO levels are associated with heart attack, stroke and …

We critically review potential involvement of trimethylamine N-oxide (TMAO) as a link
between diet, the gut microbiota and CVD. Generated primarily from dietary choline and …

ABSTRACT Background Trimethylamine N-oxide (TMAO), a compound derived from diet
and metabolism by the gut microbiome, has been associated with several chronic diseases …

ABSTRACT Background Trimethylamine-N-oxide (TMAO), a diet-derived and gut microbiota–
related metabolite, is associated with cardiovascular disease (CVD). However, major dietary …

The gut microbiota-dependent metabolite trimethylamine-N-oxide (TMAO) is linked to an
increased risk for cardiovascular diseases. Trimethylamine (TMA), which is subsequently …

High circulating trimethylamine-N-oxide (TMAO) is associated with an increased risk of
cardiovascular disease and mortality in people with chronic kidney disease (CKD). In …

Abstract Background Trimethylamine N-oxide (TMAO), the gut microbiota-dependent
metabolite, is a potential biomarker in several cardiovascular diseases. However, no study …

Abstract Plasma Trimethylamine-N-oxide (TMAO), a gut microbiota metabolite from dietary
phosphatidylcholine, is mechanistically linked to cardiovascular disease (CVD) and adverse …